Spruce Biosciences, Inc. Share Price

Spruce Biosciences, Inc. Share Price

NASDAQ: SPRB | Micro Cap
$46.71
-$0.45 (-0.95%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Spruce Biosciences, Inc. Stock Performance

Open
$48.10
Prev. Close
$47.16
Circuit Range
N/A
Day Range
$46.49 - $48.98
Year Range
$38.21 - $127.78
Volume
2,005
Average Traded
$47.86

Spruce Biosciences, Inc. Share Price Today

As of 30 October 2026, Spruce Biosciences, Inc.'s share price is $46.71. The stock opened at $48.10, compared to its previous close of $47.16. During today's trading session, Spruce Biosciences, Inc.'s share price traded between $46.49 and $48.98, with an average price of $47.74. Over the past 52 weeks, the stock has recorded a high of $127.78 and a low of $38.21. In terms of performance, Spruce Biosciences, Inc.'s share price has declined by 18.00% over the last six months and is down 56.55% on a year-on-year basis.

Spruce Biosciences, Inc. Share Price Chart

Line chart of the Spruce Biosciences, Inc. price trend over the selected period. The price fell overall, ranging from 46.49 to 49.65, ending at 46.71.
$46.49$48.98
L
Show Current Price
H

Spruce Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$35.81M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-17.87
Revenue (TTM)
$0.00
Return On Equity (TTM)
-61.33%
Profit Margin
N/A
Debt to Equity
0.08
Quarterly Earnings Growth YoY
-97.69%

Spruce Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$8.21-$14.65-$12.27-$16.23
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-78.44%16.25%-32.27%

Spruce Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$10.09$4.91$0.00
Net Profit-$46.18-$47.92-$53.04-$38.97
Net Profit MarginN/A-474.93%-1080.24%N/A
Income ChangeN/A-3.77%-10.68%26.53%

About Spruce Biosciences, Inc.

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company develops biologics and small-molecule product candidates aimed at addressing diseases with unmet medical needs and limited or no approved therapies. Its product candidate, TA-ERT for the treatment of Mucopolysaccharidosis Type IIIB (MPS IIIB), is a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase (rhNAGLU) intended as an enzyme replacement therapy for patients who lack rhNAGLU enzyme activity. TA-ERT is designed to restore rhNAGLU enzyme activity in the central nervous system following intracerebroventricular injection and promote clearance of heparan sulfate in the brain.

Spruce Biosciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$47.60
$46.90
-2.88%
Sep 2026
$55.81
$48.29
-21.96%
Aug 2026
$41.98
$61.88
+44.50%
Jul 2026
$51.69
$42.83
-21.90%
Jun 2026
$52.51
$54.84
+10.95%
May 2026
$58.25
$49.42
-13.23%
Apr 2026
$68.02
$56.96
-11.03%
Mar 2026
$53.36
$64.02
+8.01%
Feb 2026
$80.95
$59.27
-28.25%
Jan 2026
$83.02
$82.61
-2.17%
Dec 2025
$96.59
$84.44
-14.54%
Nov 2025
$107.00
$98.81
-8.08%

SPRB Share Price FAQs